Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Nigeria Pharmaceuticals and Healthcare Report, Q3 2008: Detailing the Current Market, Regulations, Competitive Landscape and Market Forecasts.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/ae57f9/nigeria_pharmaceut) has announced the addition of the "Nigeria Pharmaceuticals and Healthcare Report Q3 2008" report to their offering.

Our Nigeria Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Nigeria's pharmaceuticals and healthcare industry.

Nigeria's pharmaceutical market was estimated to be worth US$596mn in 2007. By 2012, the market should reach US$1.27bn. Growth in US dollar-terms will be boosted by a strengthening naira and expected inflation of almost 7% over the forecast period. In local currency and allowing for inflation, drug market growth should average 6.6% over the forecast period - significantly less than the headline US dollar growth rate, which should average 16.4% between 2007 and 2012.

Given that most of the population remain excluded from the genuine market due to low incomes, a wealthy elite should continue to account for most demand. Consequently, market growth will continue to be strongly linked to GDP GDP (guanosine diphosphate): see guanine. , despite attempts by the government to expand health insurance coverage through the National Health Insurance Scheme (NHIS NHIS National Health Interview Survey
NHIS New Hampshire International Speedway
NHIS National Health Insurance Scheme (Ghana)
NHIS National Health Insurance System
).

The large counterfeit drug counterfeit drug Pharmacology A formulation sold or marketed as if it were a particular proprietary substance produced by a particular manufacturer with specified ingredients, which it may or may not, in fact, contain. See Generic drug, Proprietary drug.  market as well as the fact that Nigerians predominantly pre·dom·i·nant  
adj.
1. Having greatest ascendancy, importance, influence, authority, or force. See Synonyms at dominant.

2.
 access their medicine through unofficial outlets, makes it necessary to estimate the value of pharmaceutical consumption, which is significantly higher than recorded sales. According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 a recent poll, only half of Nigerians used sources that would register retail sales - 23% used government clinics, 15% pharmacists This is a list of notable pharmacists.
  • Dora Akunyili, Director General of National Agency for Food and Drug Administration and Control of Nigeria
  • Charles Alderton (1857 - 1941), American inventor the soft drink Dr Pepper
  • George F.
 and 13% private hospitals with doctors in attendance.

A long awaited National Health Bill was passed in May 2008, which should improve the coordination of the healthcare system. According to the bill, a primary healthcare development fund is to be established to ensure that basic healthcare facilities are provided under the NHIS. The bill should help to organise healthcare funding in order to prioritise Verb 1. prioritise - assign a priority to; "we have too many things to do and must prioritize"
prioritize

grade, rate, rank, place, range, order - assign a rank or rating to; "how would you rank these students?"; "The restaurant is rated highly in the food
 goals more efficiently. Meanwhile, problems of corruption in the healthcare system resurfaced in April 2008, when alleged graft graft, in surgery: see transplantation, medical.
graft

In horticulture, the act of placing a portion of one plant (called a bud or scion) into or on a stem, root, or branch of another (called the stock) in such a way that a union forms and the
 over unspent public health funds resulted in the resignation of Health Minister Adnike Grange and Minister of State for Health Gabriel Aduku.

Despite the growth of a number of local pharmaceutical manufacturers, Nigeria remains heavily reliant on imported pharmaceuticals, with pharmaceutical exports insignificant in value terms and limited to semiregulated markets in the region. The import reliance is related to the fact that patented drugs make up the majority of the market by value, with most multinationals preferring to import high-tech products.

Key Topics Covered:

- Nigeria Pharmaceuticals And Healthcare Industry SWOT

- Nigeria Business Environment SWOT

- Market Summary

- Regulatory Regime

- Industry Developments

- Healthcare Sector

- Pharmaceutical Sector

- Industry Forecast Scenario

- Overall Market Forecasts

- Key Growth Factors

- Prescription Market Forecast

- Patented Drug Market Forecast

- Generics Market Forecast

- OTC Market Noun 1. OTC market - a stock exchange where securities transactions are made via telephone and computer rather than on the floor of an exchange
over-the-counter market
 Forecast

- Pharmaceutical Export/Import Market Forecasts

- Key Risks To Our Forecasts

- Competitive Landscape

- Company Profiles

Companies Mentioned:

- Archy

- Drugfield Pharmaceuticals Limited

- Emzor

- Fidson Healthcare

- GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company)
GSK Glycogen Synthase Kinase
GSK Gruppentraining Sozialer Kompetenzen (Germany)
GSK Greenland Shark (FAO fish species code) 
)

- Neimeth

- Neros Pharmaceuticals

- Nigeria-German Chemicals PLC (NGC NGC New General Catalogue (of Nebulae and Star Clusters; astronomy)
NGC National Geographic Channel (TV)
NGC National Guideline Clearinghouse
)

- Novartis

- Pfizer

- Sanofi-Aventis

For more information visit http://www.researchandmarkets.com/research/ae57f9/nigeria_pharmaceut
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 22, 2008
Words:494
Previous Article:A 2008 Israel Industry & Market Outlook: Providing Details of over 100 Major Israeli Industries & Forecasts for 2009.
Next Article:GreenChek Reports the Completion of Its Initial Stage of Financing.



Related Articles
The Total Pharmaceutical Market in Hungary is Forecast to Grow from US$2.71Bn in 2006 to US$3.31Bn in 2011.
Chile Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Chile's Pharmaceuticals and Healthcare Industry.
A Report on the Egyptian Pharmaceuticals and Healthcare Industry: Providing the Latest Forecasts, SWOT Analysis & Industry Developments.
Independent Forecasts and Competitive Intelligence Algeria's Pharmaceuticals and Healthcare Industry 2008, Q3.
The Latest Kazakhstan Pharmaceuticals and Healthcare Report for Q3 2008 is Now Available: Examine the Latest Statistics, Forecasts and Industry...
A Romanian Pharmaceuticals and Healthcare Report, Q3 2008: Understand the Regulatory Regime, the Competitive Landscape & Recent Developments.
A South Korea Pharmaceuticals and Healthcare Report Q3 2008: Examine Industry Trends, the Regulatory Regime & Market Opportunities.
Get the Latest Independent Forecasts and Competitive Intelligence with Hungary Pharmaceuticals and Healthcare Report Q3 2008.
Examine the Russian Pharmaceuticals and Healthcare Industry with this Essential Report, Q3 2008.
Examine the Japanese Pharmaceuticals and Healthcare Industry with This Comprehensive Report, Q3 2008.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles